APP and Alzheimer disease: However, the antibodies elicited by these vaccines bound to Aβ monomers, oligomers, fibrils, and even APP [14, 15], also leading to cerebral edema and microvascular hemorrhage in the brains of patients with AD, and they did not show remarkably therapeutic effects in the clinical trials [16–18].